Ven Bio Global Strategic Fund Ii L.P. Impel Pharmaceuticals Inc (IMPL) insider trading activity

Ven Bio Global Strategic Fund Ii L.P. is of IMPEL PHARMACEUTICALS INC. Currently has a direct ownership of 2.76 Million shares of IMPL, which is worth approximately $55,195. The most recent transaction as insider was on Apr 27, 2021, when has been sold 450,000 shares (Common Stock) at a price of $15.0 per share, resulting in proceeds of $6,750,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.76M

0% 3M change

0% 12M change

Total Value Held $55,195

venBio Global Strategic Fund II L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Apr 27 2021	BUY Open market or private purchase	$6,750,000 $15.0 p/Share	450,000 Added 14.02%	2,759,791 Common Stock
Apr 27 2021	BUY Conversion of derivative security	-	2,309,791 Added 50.0%	2,309,791 Common Stock

Also insider at

CMPI

Checkmate Pharmaceuticals, Inc.

> 10% Shareholder

vGS